Literature DB >> 9357804

Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele.

L Rossetti1, W Chen, M Hu, M Hawkins, N Barzilai, S Efrat.   

Abstract

Glucokinase (GK) catalyzes the phosphorylation of glucose in beta-cells and hepatocytes, and mutations in the GK gene have been implicated in a form of human diabetes. To investigate the relative role of partial deficiencies in the hepatic vs. pancreatic GK activity, we examined insulin secretion, glucose disposal, and hepatic glucose production (HGP) in response to hyperglycemia in transgenic mice 1) with one disrupted GK allele, which manifest decreased GK activity in both liver and beta-cells (GK+/-), and 2) with decreased GK activity selectively in beta-cells (RIP-GKRZ). Liver GK activity was decreased by 35-50% in the GK+/- but not in the RIP-GKRZ compared with wild type (WT) mice. Hyperglycemic clamp studies were performed in conscious mice with or without concomitant pancreatic clamp. In all studies [3-(3)H]glucose was infused to measure the rate of appearance of glucose and HGP during 80 min of euglycemia (Glc approximately 5 mM) followed by 90 min of hyperglycemia (Glc approximately 17 mM). During hyperglycemic clamp studies, steady-state plasma insulin concentration, rate of glucose infusion, and rate of glucose disappearance (Rd) were decreased in both GK+/- and RIP-GKRZ compared with WT mice. However, whereas the basal HGP (at euglycemia) averaged approximately 22 mg x kg(-1) x min(-1) in all groups, during hyperglycemia HGP was suppressed by only 48% in GK+/- compared with approximately 70 and 65% in the WT and RIP-GKRZ mice, respectively. During the pancreatic clamp studies, the ability of hyperglycemia per se to increase Rd was similar in all groups. However, hyperglycemia inhibited HGP by only 12% in GK+/-, vs. 42 and 45%, respectively, in the WT and RIP-GKRZ mice. We conclude that, although impaired glucose-induced insulin secretion is common to both models of decreased pancreatic GK activity, the marked impairment in the ability of hyperglycemia to inhibit HGP is due to the specific decrease in hepatic GK activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9357804     DOI: 10.1152/ajpendo.1997.273.4.E743

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  15 in total

1.  Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action.

Authors:  Haruka Okamoto; Silvana Obici; Domenico Accili; Luciano Rossetti
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

2.  Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production.

Authors:  Sylvia Kehlenbrink; Julia Tonelli; Sudha Koppaka; Visvanathan Chandramouli; Meredith Hawkins; Preeti Kishore
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-05       Impact factor: 4.310

3.  Regulation of hepatic energy metabolism and gluconeogenesis by BAD.

Authors:  Alfredo Giménez-Cassina; Luisa Garcia-Haro; Cheol Soo Choi; Mayowa A Osundiji; Elizabeth A Lane; Hu Huang; Muhammed A Yildirim; Benjamin Szlyk; Jill K Fisher; Klaudia Polak; Elaura Patton; Jessica Wiwczar; Marina Godes; Dae Ho Lee; Kirsten Robertson; Sheene Kim; Ameya Kulkarni; Alberto Distefano; Varman Samuel; Gary Cline; Young-Bum Kim; Gerald I Shulman; Nika N Danial
Journal:  Cell Metab       Date:  2014-02-04       Impact factor: 27.287

4.  Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes.

Authors:  D J Baker; A M Atkinson; G P Wilkinson; G J Coope; A D Charles; B Leighton
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

5.  Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus.

Authors:  M Mevorach; A Giacca; Y Aharon; M Hawkins; H Shamoon; L Rossetti
Journal:  J Clin Invest       Date:  1998-08-15       Impact factor: 14.808

6.  Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis.

Authors:  S Kehlenbrink; S Koppaka; M Martin; R Relwani; M-H Cui; J-H Hwang; Y Li; R Basu; M Hawkins; P Kishore
Journal:  Diabetologia       Date:  2012-07-31       Impact factor: 10.122

7.  Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-beta signaling.

Authors:  Timothy D Cummins; Michelle T Barati; Susan C Coventry; Sarah A Salyer; Jon B Klein; David W Powell
Journal:  Biochim Biophys Acta       Date:  2009-10-22

8.  Inhibition of Ca2+-independent phospholipase A2 results in insufficient insulin secretion and impaired glucose tolerance.

Authors:  Keying Song; Xu Zhang; Chunying Zhao; Natasha T Ang; Zhongmin Alex Ma
Journal:  Mol Endocrinol       Date:  2004-10-07

9.  Moderate alcohol consumption, glucose metabolism and lipolysis: the effect on adiponectin and tumor necrosis factor alpha.

Authors:  A Avogaro; M Sambataro; A Marangoni; A Pianta; R Vettor; C Pagano; M C Marescotti; A Tiengo; G Beltramello
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

Review 10.  Molecular physiology of mammalian glucokinase.

Authors:  P B Iynedjian
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.